Try our Advanced Search for more refined results

Expert Analysis

Biotech Cos. Face Pressure To Disclose

Law360, New York ( May 9, 2016, 3:50 PM EDT) -- When reacting to regulatory and clinical developments, management of a publicly-traded, clinical-stage biotechnology company, frequently may face a tension between a "duty to disclose" and the "pressure to disclose." The "duty to disclose" material information is defined by legal principles. In contrast, the "pressure to disclose" is fueled by business and market realities. While every situation will be different, when deciding when and what to disclose, there are several practical steps that can be taken by management to facilitate and support that decision....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!